Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Texas Instruments Incorporated's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $236.5B | |
|---|---|---|
| Revenue (ttm) | 20.8B | |
| Net income (ttm) | 7.1B | |
| EPS (ttm) | $7.72 | |
| Shares out | 913.8M | |
| P/E (trailing) | 40.2x | |
| P/E (forward) | 26.1x | |
| Dividend | $6.08 (1.98%) | |
| Volume | 4,126,503 | |
| Beta | 1.34 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $18.34B | $20.03B | $17.52B | $15.64B | $17.68B | -0.9% |
| Gross profit | $12.38B | $13.77B | $11.02B | $9.09B | $10.08B | -5.0% |
| Operating income | $8.96B | $10.14B | $7.33B | $5.47B | $6.02B | -9.5% |
| Net income | $7.77B | $8.75B | $6.51B | $4.80B | $5.00B | -10.4% |
| EPS (diluted) | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 | -9.9% |
| EBITDA | $10.06B | $11.23B | $8.50B | $7.54B | $8.25B | -4.8% |
| R&D | $1.55B | $1.67B | $1.86B | $1.96B | $2.08B | +7.6% |
| SG&A | $1.67B | $1.70B | $1.83B | $1.79B | $1.86B | +2.8% |
Recent company headlines from major financial publishers.
The path is supported if FY2027 revenue and diluted EPS remain within their dated forecast ranges. Results below those ranges would weaken the expected recovery.
This path raises profit and cash without requiring investors to pay a higher valuation for each dollar of earnings. Persistent heavy reinvestment would disconfirm it.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.9% | $126 | $130 | $135 | $140 | $148 |
| 8.9% | $114 | $117 | $120 | $124 | $129 |
| 9.9% | $105 | $107 | $110 | $112 | $115 |
| 10.9% | $97.8 | $99.4 | $101 | $103 | $105 |
| 11.9% | $91.7 | $92.9 | $94.3 | $95.8 | $97.4 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
